Displaying drugs 14676 - 14700 of 15432 in total
AT-GTX-502
AT-GTX-502 is an experimental, one-time gene therapy that uses AAV9 to deliver a functional copy of CLN3.
Investigational
BMN-045
Experimental
Withdrawn
AVI-014
AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).
Investigational
Autologous Human Peripheral Blood Lymphocytes
Investigational
BGA002
Investigational
SRX-1177
Investigational
Activated natural killer cell therapy
Investigational
Adenovirus/PNP
Investigational
ETBX-041
Investigational
Carlecortemcel-L
Investigational
PBCAR269A
Investigational
PBCAR20A
Investigational
P-2045 Re-188
Investigational
KAb201
Investigational
hu3S193
Investigational
Pritumumab
Investigational
Tamrintamab pamozirine
Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
Investigational
JCAR014
Investigational
Letetresgene autoleucel
Investigational
M-032
Investigational
Zevorcabtagene autoleucel
Investigational
Galinpepimut-S
Investigational
ST101 peptide
ST101 is a cell-penetrating peptide that disrupts the protein-protein interactions driving ATF5-regulated gene transcription.
Investigational
ONCOS-102
Investigational
Displaying drugs 14676 - 14700 of 15432 in total